Trending Tickers: Actavis plc (NYSE:ACT), AK Steel Holding Corporation (NYSE:AKS), Versar Inc. (NYSEMKT:VSR), Signal Genetics, Inc. (NASDAQ:SGNL), Allied Nevada Gold Corp. (NYSEMKT:ANV)

Actavis PLC (NYSE:ACT) agreed to pay about $66 billion for Allergan Inc., the maker of the antiwrinkle treatment Botox, in the year’s biggest pharmaceutical deal. The cash-and-stock purchase, in which Actavis will pay $219 a share, also puts an end to Valeant Pharmaceuticals International Inc.’s months-long hostile takeover fight for Allergan, a move backed by activist investor Bill Ackman. Actavis plc (NYSE:ACT) belongs to Healthcare … Continue reading Trending Tickers: Actavis plc (NYSE:ACT), AK Steel Holding Corporation (NYSE:AKS), Versar Inc. (NYSEMKT:VSR), Signal Genetics, Inc. (NASDAQ:SGNL), Allied Nevada Gold Corp. (NYSEMKT:ANV)

Colin Pettis11/2011/20

Active Stocks to Watch : Bank of America Corporation (NYSE:BAC), Actavis plc (NYSE:ACT), Actions Semiconductor Co., Ltd. (NASDAQ:ACTS), General Motors (NYSE:GM), BA

Bank of America Corporation (NYSE:BAC) announced the Board of Directors declared a regular quarterly cash dividend on Bank of America common stock of $0.05 per share, payable December 26 to shareholders of record as of December 5. Bank of America Corporation (NYSE:BAC) belongs to Financial sector. Its net profit margin is 8.80% and weekly performance is 3.15%. On last trading day company shares ended up … Continue reading Active Stocks to Watch : Bank of America Corporation (NYSE:BAC), Actavis plc (NYSE:ACT), Actions Semiconductor Co., Ltd. (NASDAQ:ACTS), General Motors (NYSE:GM), BA

Kristen Barton10/2710/27

Active Stocks : Amgen Inc. (NASDAQ:AMGN), MagnaChip Semiconductor Corporation (NYSE:MX), Actavis plc (NYSE:ACT), Ducommun Inc. (NYSE:DCO), the Rubicon Project, Inc. (NYSE:RUBI)

A coalition of companies and groups like the Bill & Melinda Gates Foundation and Amgen Inc. (NASDAQ:AMGN) with offices in Seattle and Bothell, are working together to produce more of the experimental Ebola drug ZMapp, Bloomberg reported on Friday. Amgen Inc. (NASDAQ:AMGN) belongs to Healthcare sector. Its net profit margin is 25.70% and weekly performance is 2.96%. On last trading day company shares ended up … Continue reading Active Stocks : Amgen Inc. (NASDAQ:AMGN), MagnaChip Semiconductor Corporation (NYSE:MX), Actavis plc (NYSE:ACT), Ducommun Inc. (NYSE:DCO), the Rubicon Project, Inc. (NYSE:RUBI)

Colin Pettis10/2110/21

Morning Watch List : Actavis plc (NYSE:ACT), Google Inc (NASDAQ:GOOGL), Rouse Properties, Inc. (NYSE:RSE), DCP Midstream Partners LP (NYSE:DPM), Titan Machinery (NASDAQ:TITN)

Actavis plc (NYSE:ACT) confirmed Thursday that it has filed an Abbreviated New Drug Application or ANDA with the U.S. Food and Drug Administration or FDA seeking approval to market Methylphenidate Hydrochloride for Extended-release Oral Suspension, 5 mg/mL. Actavis plc (NYSE:ACT) belongs to Healthcare sector. Its net profit margin is 0.60% and weekly performance is -8.34%. On last trading day company shares ended up $222.07. Actavis … Continue reading Morning Watch List : Actavis plc (NYSE:ACT), Google Inc (NASDAQ:GOOGL), Rouse Properties, Inc. (NYSE:RSE), DCP Midstream Partners LP (NYSE:DPM), Titan Machinery (NASDAQ:TITN)

Colin Pettis10/1710/17

Morning Alert : Actavis (NYSE:ACT), Borderfree (NASDAQ:BRDR), Sohu.com (NASDAQ:SOHU), Rowan Companies (NYSE:RDC), Platform Specialty Products (NYSE:PAH)

Actavis plc’s (NYSE:ACT) new drug application (NDA) for its antibiotic candidate, ceftazidime-avibactam, has been accepted for review by the FDA. Actavis is looking to get ceftazidime-avibactam approved for the treatment of patients with complicated urinary tract infections (cUTI) and complicated intra-abdominal infections (cIAI), including those caused by multi-drug resistant gram-negative bacterial pathogens. Actavis plc (NYSE:ACT) belongs to Healthcare sector. Its net profit margin is 0.60% … Continue reading Morning Alert : Actavis (NYSE:ACT), Borderfree (NASDAQ:BRDR), Sohu.com (NASDAQ:SOHU), Rowan Companies (NYSE:RDC), Platform Specialty Products (NYSE:PAH)

Ryan Holtz09/0909/09